SCHEMBL27588474

SCHEMBL27588474

COc1ccc(CC2=CC=N[N]2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LTA4H P09960 1/20 0.48
▸ ALDH1A1 P00352 5/20 0.44
▸ LMNA P02545 2/20 0.44
▸ CYP2D6 P10635 1/20 0.44
▸ ATM Q13315 1/20 0.44
▸ SMN1; SMN2 Q16637 1/20 0.44
▸ IDO1 P14902 2/20 0.42
▸ HPGD P15428 1/20 0.41
▸ POLB P06746 1/20 0.41
▸ AGXT P21549 1/20 0.40
▸ SAE1 Q9UBE0 1/20 0.40
▸ UBA2 Q9UBT2 1/20 0.40
▸ TAAR1 Q96RJ0 1/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ MPI P34949 1/20 0.40
▸ APOBEC3G Q9HC16 1/20 0.40
▸ HTT P42858 1/20 0.40
▸ CA12 O43570 1/20 0.39
▸ CA1 P00915 1/20 0.39
▸ CA2 P00918 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27588567 0.76 CYP3A4 (0.50) ALDH1A1LMNASMN1; SMN2CA12CA1
SCHEMBL27606385 0.76 HRH3 (0.39) TAAR1CA12CA1CA2CA7
SCHEMBL1425001 0.73 LTA4H (0.81) LTA4HALDH1A1LMNACYP2D6ATM
SCHEMBL25986524 0.73 LTA4H (0.81) LTA4HALDH1A1LMNACYP2D6ATM
SCHEMBL27884 0.73 LTA4H (0.81) LTA4HALDH1A1LMNACYP2D6ATM
SCHEMBL27543797 0.73 CYP17A1 (0.38) ALDH1A1CYP2D6SMN1; SMN2HPGDPOLB
Ammonia Solution, Strong SCHEMBL20919857 0.71 LTA4H (0.77) LTA4HALDH1A1LMNACYP2D6ATM
SCHEMBL27606510 0.68 TP53 (0.46) ALDH1A1SMN1; SMN2HPGDKDM4ECA12
SCHEMBL24321390 0.68 LTA4H (0.71) LTA4HALDH1A1LMNACYP2D6ATM
SCHEMBL22451382 0.68 LTA4H (0.71) LTA4HALDH1A1LMNACYP2D6ATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1553900-A Acylsemicarbazides as cyclin dependent kinase inhibitors useful as anti-cancer and anti-proliferative agents ��ʱ��ʩ����ҩ��˾ 2004-12-08 — — CN disclosed
Send feedback